Kaida BioPharma Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Sep 1, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jan 21, 2026 · D | Sep 1, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $3,000,000 | $4,100,507 | $1,100,507 |
| Reported amount sold | $1,570,507 | $1,600,507 | $30,000 |
| Reported investor count | — | 44 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001493152-26-003028 · Later SEC source: 0001493152-26-040893
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $4,100,507
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $1,600,507
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Same reported sales compensation recipient
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- 116 Street Ventures Fund 7, LLC · CIK 2065713
- 116 Street Ventures Fund 8, LLC · CIK 2115645
- 164 Ridgeline E&H SPV, LLC · CIK 2089852
- 1911 WATERTOWN SPV LLC · CIK 2106864
- 1st American Nuclear Co. · CIK 2074867
Form D filings (2)
-
0001493152-26-040893D/A · Sep 1, 2026 · BiotechnologyOffering: $4,100,507Sold: $1,600,507
Compared with 0001493152-26-003028:
- Reported offering amount: $3,000,000 → $4,100,507
- Reported amount sold: $1,570,507 → $1,600,507
- Reported investor count: Unavailable → 44
-
0001493152-26-003028D · Jan 21, 2026 · BiotechnologyOffering: $3,000,000Sold: $1,570,507